Modafinil vs placeboQuality of life: 1a. Average endpoint scores on various scales (MSQoL‐54, high = good) ‐ short term · schizophrenia or related disorders1 finding from 1 reviewModafinil for people with schizophrenia or related disorders 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 20 participantsVery low
Porter 2020: armodafinil vs placeboQuality of life, self‐rated at post‐treatment · people with a primary brain tumour1 finding from 1 reviewInterventions for the management of fatigue in adults with a primary brain tumour 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 232 participantsLow